{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:34:50Z","timestamp":1765805690160,"version":"3.40.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.mcna.2012.07.003","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T08:08:38Z","timestamp":1347523718000},"page":"933-942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diuretics in Heart Failure"],"prefix":"10.1016","volume":"96","author":[{"given":"Jagroop","family":"Basraon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash C.","family":"Deedwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mcna.2012.07.003_bib1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure","volume":"57","author":"Vargo","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.mcna.2012.07.003_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/clpt.1987.131","article-title":"Clinical pharmacology of torsemide, a new loop diuretic","volume":"42","author":"Brater","year":"1987","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.mcna.2012.07.003_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/clpt.1983.154","article-title":"Bumetanide and furosemide","volume":"34","author":"Brater","year":"1983","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.mcna.2012.07.003_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/bdd.2510070602","article-title":"Pharmacokinetics of the thiazide diuretics","volume":"7","author":"Welling","year":"1986","journal-title":"Biopharm Drug Dispos"},{"issue":"5 Pt 1","key":"10.1016\/j.mcna.2012.07.003_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cpt1976195part1531","article-title":"Absorption, metabolism, and excretion of hydrochlorothiazide","volume":"19","author":"Beermann","year":"1976","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.mcna.2012.07.003_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cpt1974164659","article-title":"Pharmacokinetics of furosemide in advanced renal failure","volume":"16","author":"Huang","year":"1974","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.mcna.2012.07.003_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.mcna.2009.03.007","article-title":"Ascites: diagnosis and management","volume":"93","author":"Hou","year":"2009","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.1016\/j.mcna.2012.07.003_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/clpt.1981.189","article-title":"Furosemide kinetics in patients with hepatic cirrhosis with ascites","volume":"30","author":"Fuller","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mcna.2012.07.003_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/clpt.1986.132","article-title":"Furosemide kinetics and dynamics in patients with cirrhosis","volume":"40","author":"Villeneuve","year":"1986","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mcna.2012.07.003_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-3565(25)32257-3","article-title":"Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man","volume":"215","author":"Chennavasin","year":"1980","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.mcna.2012.07.003_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ki.1979.120","article-title":"Pharmacodynamic analysis of the furosemide-probenecid interaction in man","volume":"16","author":"Chennavasin","year":"1979","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mcna.2012.07.003_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/clpt.1988.186","article-title":"Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure","volume":"44","author":"Cook","year":"1988","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.mcna.2012.07.003_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mcna.2012.07.003_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cardfail.2008.01.015","article-title":"The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients","volume":"14","author":"Mielniczuk","year":"2008","journal-title":"J\u00a0Card Fail"},{"issue":"3","key":"10.1016\/j.mcna.2012.07.003_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cardfail.2009.11.005","article-title":"Continuous versus intermittent infusion of furosemide in acute decompensated heart failure","volume":"16","author":"Thomson","year":"2010","journal-title":"J\u00a0Card Fail"},{"issue":"2","key":"10.1016\/j.mcna.2012.07.003_bib16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0735-1097(96)00161-1","article-title":"Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion","volume":"28","author":"Dormans","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.mcna.2012.07.003_bib17","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.amjcard.2010.01.355","article-title":"Continuous versus bolus dosing of furosemide for patients hospitalized for heart failure","volume":"105","author":"Allen","year":"2010","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.mcna.2012.07.003_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2012.07.003_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1527-5299.2003.01907.x","article-title":"Metolazone and its role in edema management","volume":"9","author":"Sica","year":"2003","journal-title":"Congest Heart Fail"},{"issue":"6274","key":"10.1016\/j.mcna.2012.07.003_bib20","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/bmj.282.6274.1432","article-title":"Synergistic action of metolazone with \"loop\" diuretics","volume":"282","author":"Ghose","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"10.1016\/j.mcna.2012.07.003_bib21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-3565(25)21144-2","article-title":"Mechanisms of the synergistic combination of metolazone and bumetanide","volume":"233","author":"Brater","year":"1985","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"19","key":"10.1016\/j.mcna.2012.07.003_bib22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.mcna.2012.07.003_bib23","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","article-title":"Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction","volume":"100","author":"Cooper","year":"1999","journal-title":"Circulation"},{"issue":"6 Pt 2","key":"10.1016\/j.mcna.2012.07.003_bib24","first-page":"F1269","article-title":"Adaptation of distal tubule and collecting duct to increased Na delivery. II. Na+ and K+ transport","volume":"255","author":"Stanton","year":"1988","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.mcna.2012.07.003_bib25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ki.1995.124","article-title":"Tubular hypertrophy due to work load induced by furosemide is associated with increases of IGF-1 and IGFBP-1","volume":"47","author":"Kobayashi","year":"1995","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.mcna.2012.07.003_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0002-9629(15)40676-7","article-title":"Diuretic complications","volume":"319","author":"Greenberg","year":"2000","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.mcna.2012.07.003_bib27","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ki.1985.229","article-title":"Diuretic-induced hypokalemia","volume":"28","author":"Tannen","year":"1985","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.mcna.2012.07.003_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0002-9343(78)90177-8","article-title":"Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study","volume":"64","author":"Helgeland","year":"1978","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.mcna.2012.07.003_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2165\/00003495-198121030-00003","article-title":"The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics","volume":"21","author":"Johnson","year":"1981","journal-title":"Drugs"},{"issue":"19","key":"10.1016\/j.mcna.2012.07.003_bib30","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000165065.82609.3D","volume":"111","author":"Klein","year":"2005","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.mcna.2012.07.003_bib31","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mcna.2012.07.003_bib32","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mcna.2012.07.003_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfg547","article-title":"Erythropoietin protects against ischaemic acute renal injury","volume":"19","author":"Vesey","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.mcna.2012.07.003_bib34","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/01.HYP.0000039506.43589.D5","article-title":"Angiotensin II and oxidative stress in Dahl salt-sensitive rat with heart failure","volume":"40","author":"Tojo","year":"2002","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.mcna.2012.07.003_bib35","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/eurheartj\/ehl542","article-title":"Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry","volume":"28","author":"Gheorghiade","year":"2007","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.mcna.2012.07.003_bib36","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N\u00a0Engl J Med"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712512001253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712512001253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:29:30Z","timestamp":1744115370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712512001253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0025712512001253"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2012.07.003","relation":{},"ISSN":["0025-7125"],"issn-type":[{"type":"print","value":"0025-7125"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diuretics in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2012.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}